{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T04:30:17Z","timestamp":1721881817113},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1006\/gyno.2001.6205","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T22:50:18Z","timestamp":1032303018000},"page":"77-83","source":"Crossref","is-referenced-by-count":7,"title":["Synthetic Peptides Induce a Cytotoxic Response against Human Papillomavirus Type-18"],"prefix":"10.1006","volume":"82","author":[{"given":"Mario R.","family":"Castellanos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta L.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell A.","family":"Maiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2001.6205_RF1","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJM199604183341606","article-title":"Cancer of the uterine cervix","volume":"334","author":"Cannistra","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1006\/gyno.2001.6205_RF2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ijc.2910540413","article-title":"Estimates of the worldwide incidence of eighteen major cancers in 1985","volume":"54","author":"Parkin","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1006\/gyno.2001.6205_RF3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/00034983.1995.11812977","article-title":"Human papillomaviruses, cervical cancer and the developing world","volume":"89","author":"Birley","year":"1995","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1006\/gyno.2001.6205_RF4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0889-8545(05)70275-8","article-title":"The genetic program of genital human papillomaviruses in infection and cancer","volume":"23","author":"Turek","year":"1996","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1006\/gyno.2001.6205_RF5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0046-8177(92)90232-R","article-title":"Human papillomavirus type-16 and 18 gene expression in cervical neoplasias","volume":"23","author":"Stoler","year":"1992","journal-title":"Hum Pathol"},{"key":"10.1006\/gyno.2001.6205_RF6","first-page":"579","article-title":"The role of human papillomavirus in anogenital cancer","volume":"23","author":"Pfister","year":"1996","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1006\/gyno.2001.6205_RF7","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.4049\/jimmunol.156.6.2186","article-title":"Identification of a contact region for peptide on the TAP1 chain of the transporter associated with antigen processing","volume":"156","author":"Nijenhuis","year":"1996","journal-title":"J Immunol"},{"key":"10.1006\/gyno.2001.6205_RF8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60885-8","article-title":"Proteasome and antigen processing","volume":"64","author":"Tanaka","year":"1997","journal-title":"Adv Immunol"},{"key":"10.1006\/gyno.2001.6205_RF9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF02918250","article-title":"Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation","volume":"15","author":"Yang","year":"1996","journal-title":"Immunol Res"},{"key":"10.1006\/gyno.2001.6205_RF10","first-page":"582","article-title":"Occasional memory cytotoxic T-cell response of patients with human papillomavirus type-16-positive cervical lesions against a human leukocyte antigen-A*0201-restricted E7-encoded epitope","volume":"56","author":"Ressing","year":"1996","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2001.6205_RF11","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0002-9378(96)70110-2","article-title":"Generation of tumor-specific cytotoxic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type-16 E7 epitope","volume":"175","author":"Alexander","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6205_RF12","doi-asserted-by":"crossref","first-page":"5934","DOI":"10.4049\/jimmunol.154.11.5934","article-title":"Human CTL epitopes encoded by human papillomavirus type-16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of the HLA-A*201-binding peptides","volume":"154","author":"Ressing","year":"1995","journal-title":"J Immunol"},{"key":"10.1006\/gyno.2001.6205_RF13","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1002\/eji.1830250935","article-title":"Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type-16-induced tumors","volume":"25","author":"Feltkamp","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1006\/gyno.2001.6205_RF14","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/eji.1830230929","article-title":"Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type-16-transformed cells","volume":"23","author":"Feltkamp","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1006\/gyno.2001.6205_RF15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective.International biology study on cervical cancer (IBSCC) study group","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.2001.6205_RF16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0168-1702(98)00008-2","article-title":"Synthetic peptides of human papillomavirus type-18 E6 harboring HLA-A2.1 motif can induce peptide-specific cytotoxic T-cells from peripheral blood mononuclear cells of healthy donors","volume":"54","author":"Yoon","year":"1998","journal-title":"Virus Res"},{"key":"10.1006\/gyno.2001.6205_RF17","unstructured":"Castellanos, M, R, Hayes, R, L, A simple algorithm to identify potential cytotoxic T-lymphocytes epitopes from HLA-A2(+) donors. Submitted for publication."},{"key":"10.1006\/gyno.2001.6205_RF18","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.4049\/jimmunol.152.8.3904","article-title":"Role of HLA-A motifs. Identification of potential CTL epitopes in human papillomavirus type-16 E6 and E7 proteins","volume":"152","author":"Kast","year":"1994","journal-title":"J Immunol"},{"key":"10.1006\/gyno.2001.6205_RF19","first-page":"929","article-title":"Prominent role of secondary anchor residues in peptide binding to HLA-A2.1","volume":"74","author":"Ruppert","year":"1993","journal-title":"Mol Cell"},{"key":"10.1006\/gyno.2001.6205_RF20","first-page":"30","article-title":"An improved method for the detection of peptide-induced upregulation of HLA-A2 molecules on TAP-deficient T2 cells","volume":"13","author":"Regner","year":"1996","journal-title":"Exp Clin Immunogenet"},{"key":"10.1006\/gyno.2001.6205_RF21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0889-8545(05)70280-1","article-title":"Anogenital papillomavirus infection and neoplasia in immunodeficient women","volume":"23","author":"Wright","year":"1996","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1006\/gyno.2001.6205_RF22","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0002-9378(88)80070-X","article-title":"Analysis of individual human papillomavirus types in cervical, neoplasia: a possible role for type-18 in rapid progression","volume":"159","author":"Kurman","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6205_RF23","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9378(99)70256-5","article-title":"Risk factors for rapid-onset cervical cancer","volume":"180","author":"Hildesheim","year":"1999","journal-title":"Am J Obstet Gynecol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801962055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801962055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T02:34:05Z","timestamp":1680575645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825801962055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S0090825801962055"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2001.6205","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}